EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

β-Hydroxybutyrate Inhibits Angiogenesis, Suppresses Non-Small Cell Lung Cancer Growth, and Enhances Gemcitabine Antitumor Activity

Yomna Labanie, Kholoud Arafat, Shahrazad Sulaiman, Aya Mudhafar Al-Azawi, Samir Attoub

International Journal of Molecular Sciences · 04.06.2026 · 27 (11) · 5103

DOI: 10.3390/ijms27115103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.06.2026. Verfasst von Yomna Labanie und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Therapeutics, College of Medicine & Health Sciences, United Arab Emirates University, Al-Ain 15551, United Arab Emirates. Hauptthemen laut MEDLINE: Deoxycytidine, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, 3-Hydroxybutyric Acid. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: College of Medicine and Health Sciences (CMHS) / United Arab Emirates University, No. 12M177. This research was partially supported by ASPIRE, the technology p….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer remains the most prevalent malignancy and the leading cause of cancer-related mortality worldwide, highlighting the need for novel therapeutic strategies. β-Hydroxybutyrate (BHB), the primary circulating ketone body, has shown antitumor activity in other cancers, but its role in non-small cell lung cancer (NSCLC) is not well defined. This study investigated the anticancer and anti-angiogenic effects of BHB alone and in combination with Gemcitabine using in vitro and in vivo approaches. In A549 (adenocarcinoma) and LNM35 (large-cell carcinoma) NSCLC cells, BHB significantly reduced cell number and colony growth in a concentration-dependent manner, with LNM35 cells exhibiting greater sensitivity. Migration of both A549 and LNM35 cells was also markedly inhibited. In endothelial Telo-HAEC cells, BHB exhibited no cytotoxicity but significantly inhibited migration, tube formation, and VEGF-induced spheroid sprouting, indicating anti-angiogenic activity. Combination studies showed that BHB enhanced Gemcitabine-mediated suppression of NSCLC cell number and colony growth, consistent with an additive to synergistic effect. In the chick embryo chorioallantoic membrane model, BHB and Gemcitabine reduced tumor growth individually, while their combination further decreased tumor weight, particularly in LNM35 xenografts, without observable toxicity. These findings provide preclinical evidence that BHB enhances Gemcitabine antitumor activity against NSCLC and reveals its in vitro anti-angiogenic effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DeoxycytidineCarcinoma, Non-Small-Cell LungLung Neoplasms3-Hydroxybutyric AcidNeovascularization, PathologicAngiogenesis InhibitorsGemcitabineHumansAnimalsCell MovementCell ProliferationCell Line, TumorMiceXenograft Model Antitumor AssaysDrug SynergismChick EmbryoA549 Cells

Stichwörter der Autor:innen

NSCLCangiogenesiscolony growthgemcitabinemigrationtumor growthβ-hydroxybutyrate

Substanzen

GemcitabineDeoxycytidine3-Hydroxybutyric AcidAngiogenesis Inhibitors

Autor:innen und Institutionen

  • Department of Pharmacology & Therapeutics, College of Medicine & Health Sciences, United Arab Emirates University, Al-Ain 15551, United Arab Emirates.
  • ASPIRE Precision Medicine Research Institute Abu Dhabi, United Arab Emirates University, Al-Ain 15551, United Arab Emirates.

Förderung

  • College of Medicine and Health Sciences (CMHS) / United Arab Emirates University, No. 12M177. This research was partially supported by ASPIRE, the technology p…

Zitieren

APA

Labanie, Y., Arafat, K., Sulaiman, S., Al-Azawi, A. M., & Attoub, S. (2026). β-Hydroxybutyrate Inhibits Angiogenesis, Suppresses Non-Small Cell Lung Cancer Growth, and Enhances Gemcitabine Antitumor Activity. International Journal of Molecular Sciences, 27(11), 5103. https://doi.org/10.3390/ijms27115103

Vancouver

Labanie Y, Arafat K, Sulaiman S, Al-Azawi AM, Attoub S. β-Hydroxybutyrate Inhibits Angiogenesis, Suppresses Non-Small Cell Lung Cancer Growth, and Enhances Gemcitabine Antitumor Activity. International Journal of Molecular Sciences. 2026;27(11):5103. doi:10.3390/ijms27115103

BibTeX
@article{Labanie2026,
  author = {Labanie, Yomna and Arafat, Kholoud and Sulaiman, Shahrazad and Al-Azawi, Aya Mudhafar and Attoub, Samir},
  title = {β-Hydroxybutyrate Inhibits Angiogenesis, Suppresses Non-Small Cell Lung Cancer Growth, and Enhances Gemcitabine Antitumor Activity},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {11},
  pages = {5103},
  doi = {10.3390/ijms27115103}
}
Kostenlos starten →